Jim Inglese, PhD
Deputy Director
NIH Chemical Genomics Center (NCGC)

The NCGC is an industrial-scale high-tech screening laboratory that functions within Molecular Libraries Screening Center Network to discover small molecule modulators of cellular and biochemical processes. Dr. Inglese received his BS in Chemistry at the Rensselaer Polytechnic Institute, and his PhD in Organic Chemistry from the Pennsylvania State University. He was a postdoctoral fellow in the laboratory of Prof. Robert J. Lefkowitz at the Howard Hughes Medical Institute at Duke University where he studied and cloned members of an emerging protein kinase family involved in the desensitization of G protein-coupled receptors. After his postdoctoral training, Dr. Inglese joined the Princeton-based biotech company, Pharmacopeia, Inc. There he and his group developed assay methods and paradigms to screen non-peptide combinatorial libraries. Prior to joining the NIH, Dr. Inglese was responsible for technology evaluation and managing HTS assay development at the Merck Research Laboratories. Dr. Inglese is the author and inventor on over 70 scientific publications and patents. Dr. Inglese is the Founding Editor and Editor-in-Chief of the peer-reviewed journal, ASSAY and Drug Development Technologies.